Prediction of efficacy of interferon treatment of chronic hepatitis C by multivariate analysis and a new classification

Pathology International

Volumn 48, Issue 3, 1998, Pages 215-220

  Kim, Soo Ryang ^a   Hayashi, Yoshitake ^b   Yoon, Seitetsu ^b   Taniguchi, Miyuki ^a   Yang, Moo Kwan ^a   Kim, Ke Ih ^a   Kim, Myung Mi ^a   Saeki, Keizo ^c   Nukata, Isao ^c   Imoto, Susumu ^a  

^a KOBE ASAHI HOSPITAL   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c Midori Hospital   (Japan)

Author keywords

Chronic hepatitis; HCV RNA; Histological activity Index; Interferon; Liver fibrosis

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 14444281995     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03895.x     Document Type: Article

References (25)

1. Hoofnagle JH, Mullen KD, Jones DB et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: A preliminary report. N. Engl. J. Med. 1986; 315: 1575-1578.
2. Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial. N. Engl. J. Med. 1989; 321: 1501-1506.
3. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 1989; 321: 1506-1510.
4. Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV-RNA strands in chronic hepatitis C: Different patterns of response to interferon treatment. Hepatology 1993; 18: 1050-1054.
5. Uchida T, Taira M, Shikata T et al. Histological difference between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol. Jpn. 1993; 43: 230-236.
6. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
7. Masao Omata. 'Live' Discussion on New Classification of Chronic Hepatitis. Churchill Livingstone Japan, Tokyo, 1996.
8. Bedossa P, Bioulac-Sage P, Callard P et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
10. Hagiwara H, Hayashi N, Mita E et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 1992; 15: 37-41.
11. Okamoto H, Kurai K, Okada S et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 1992; 188: 331-341.
12. Roffi L, Mels GC, Antonelli G et al. Breakthrough during recombinant interferon-α therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management. Hepatology 1995; 21: 645-649.
13. Shindo M, Di Bisceglie AM, Cheung L et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann. Intern. Med. 1991; 115: 700-704.
14. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J. Hepatol. 1992; 14: 35-40.
15. Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-299.
16. Tsubota A, Chayama K, Ikeda K et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-1094.
17. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantitation of hepatitis C virus by competitive reverse transcription-polymerase reaction: Increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
18. Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon-α therapy. Gastroenterology 1993; 104: 877-883.
19. De Groote J, Desmet VJ, Gedigk P et al. A classification of chronic hepatitis. Lancet 1968; 2: 626-628.
20. Ishak KG. Chronic hepatitis: Morphology and nomenclature. Mod. Pathol. 1994; 7: 690-713.
21. Ludwig J. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology 1993; 105: 274-278.
22. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol. 1991; 13: 372-374.
23. Cooksley WGE, Bradbear RA, Robinson W et al. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 1986; 6: 345-348.
24. Chen T-J, Liaw Y-F. The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: A histopathologic study. Liver 1988; 8: 10-16.
25. Bianchi L, Gudat F. Chronic hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, Portmann B, Burt AD, eds. Pathology of the Liver, 3rd edn. Churchill Livingstone, Edinburgh, 1994; 349-395.